SkinQ Daily Gental Cleanser for Pollution mix Dirt

An Open Label Clinick Study to evaluate the cleansing Efficacy of SkinQ Daily Gentle Cleanser for Pollution mix Dirt - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/01/100849

Enrollment

Registered

2026-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: SkinQ Daily Gental Cleanser: Test Product: SkinQ Daily Gentle cleanser, Apply polution mix dirt on face evenly wait till it settle down on face. Route of administration: T

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gender: Male or Female 18 to 45 2) Subjects willing to give written informed consent. 3) Volunteers with Normal to dry skin 4) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 5) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 6) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2. Use of systemic acne medications (e.g., oral isotretinoin within past 6 months) or topical prescription acne medications within 4 weeks. 2. Significant dermatologic conditions other than acne that could interfere with assessments. 3. Known sensitivity to product ingredients. 4. Recent facial procedures (chemical peels, lasers) within 4 weeks. 5. Have participated in any interventional clinical trial in the previous 90 days. 6. Have a known sensitivity to any of the constituents of the test product 7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids. 8. Have not skin related issues.

Design outcomes

Primary

Measure	Time frame
Change in pH Change in TEWL Dermascope imagingTimepoint: T0min, T+15 mins	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results